Biologists were able to include “repair DNA” in tumor cells

Biologists were able to include “repair DNA” in tumor cells


As you know, cancer cells are, in fact, the cells of our body that for one reason or another “went crazy” and began to divide uncontrollably. In these cells, among other things, broken DNA, and many drugs affect it. But a group of researchers from St. Petersburg have created a drug that makes cancer cells to repair their DNA and subsequently self-destruct.

The majority of cancer tumors arises because of the failure of the p53 gene, which is responsible for the synthesis of a particular protein that monitors the integrity of the genetic information. In case of serious disturbances in the DNA structure triggered apoptosis the mechanism of cell death. It works in a healthy organism, but in tumor cells due to destruction of p53 gene apoptosis is not triggered, although the DNA of the cells greatly affected. As stated by the Professor of the St.-Petersburg state Institute of technology Alexander Garabadzhiu,

“We have completed experiments with a new class of activators of protein p53. Activity of created connections is much higher than the most powerful drugs developed in the advanced scientific centers of the USA and Europe. Drugs based on them can become a new step towards creating effective and safe products for chemotherapy.”

In practice, however, not only a “turn on” p53. Sometimes the system described above does not work due to the high activity of the protein MDM2, which neutralises p53 molecules in healthy cells to prevent their premature self-destruction. In mutated cells MDM2 begins to work against us. A group of scientists from St. Petersburg, having studied the structure of MDM2, came to the conclusion that by changing the structure of some aromatic hydrocarbons, it is possible to achieve what they connect with MDM2 and neutralize it. Having multiple versions of products-activators, the experts have tested them in the laboratory.

“We tested the drugs on cultures of cells extracted from cancerous tumors in the rectum and in human bone. These experiments showed that the compounds successfully inhibit MDM2 and p53 include, killing about 40% of cancer cells”.